RELATED CONTENT
IBA announced the first irradiation of a Spot Scanning Proton Arc (SPArc) plan at the Beaumont Health Proton Therapy Center in Royal Oak, Mich., on its single-room proton therapy solution Proteus One.
October 25, 2018 
October 19, 2018 – IBA (Ion Beam Applications S.A.) is sharing how hospitals can secure performance, investment and ...
October 19, 2018 
myQA Daily from IBA Dosimetry enables fast as well as high-quality daily linac QA. More measurement points allow more ...
October 18, 2018 
IBA (Ion Beam Applications S.A.) announced it has entered into an agreement with Varian with the goal of validating the Dolphin transmission detector for online monitoring of patient treatment.
October 17, 2018 
As one of the more precise methods of delivering radiation therapy for cancer treatment, proton therapy has grown at a rapid pace the last several years. Considered experimental not too long ago and used primarily in research settings, clinicians across the globe are rapidly coming to accept the utility of proton therapy for numerous indications — a list that many expect to continue to grow rapidly.
August 08, 2018 
IBA (Ion Beam Applications S.A.) announced that they completed the first two installations of the Proteus One proton therapy solution in Japan. The first installation took place at the Hokkaido Ohno Memorial Hospital in Sapporo and the other at the Narita Memorial Proton Center in Toyohashi. Both installations were successful, according to the company, as the Hokkaido Ohno Memorial Hospital installation took less than 12 months and the Narita Memorial Proton Center installation took less than 11 months.
July 30, 2018 
IBA (Ion Beam Applications S.A.) announced the market launch of its new SmartScan solution at the 60th annual American Association of Physicists in Medicine (AAPM) meeting, July 29-Aug. 2 in Nashville.
July 27, 2018 
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at the recent European Society for Radiotherapy and Oncology (ESTRO) 37 Congress, April 20-24 in Barcelona, Spain.
May 31, 2018 
January 25, 2018 – IBA (Ion Beam Applications SA) has announced that the University Medical Center Groningen (UMCG) ...
January 25, 2018 
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian Halcyon machine in Europe to go clinical, at the hospital UZ Leuven in Belgium, using IBA Dosimetry’s Blue Phantom water phantom system.
January 02, 2018